By Randall
Turk
The Norman Transcript
Construction has begun on a
$3.2 million corporate headquarters and manufacturing plant for
Bio-Cide International, Inc.
To occupy a 2.5-acre tract in
Northport Industrial Park, the 28,000-square-foot plant will have
state-of-the-art laboratories and manufacturing equipment occupying
two-thirds of the space.
The corporate offices will
include a research library, conference rooms and areas for product
display, research, marketing and accounting. Completion is expected
by mid-2007.
"We're out of space," said Bob
Danner, president. Increasing business volume and higher standards
for quality control created a need for an updated facility, he
said.
The building, designed by
Chickasha architect Phillip Burk, will utilize precast tilt-up
concrete walls and a precast concrete roof. The administrative
portion will be of pre-finished metal panels, smooth split concrete
block and glass. Construction manager is CMS Willowbrook
Construction of Chickasha.
Bio-Cide International creates
and distributes proprietary oxy-chlorine products to control
bacteria and other microorganisms. The products are used in food
processing, health-care, environmental control equipment and other
specialty applications. The company's products are tested and
certified to meet government standards in the U.S. and aboard.
Bio-Cide meets ISO 9000, the international standard of product
quality.
"Everything we do has to be
approved by the federal government," Danner said. Bio-Cide
undergoes regular audits by the U.S. Food & Drug Administration
(FDA), the Environmental Protection Administration (EPA), the U.S.
Department of Agriculture (USDA) and several pharmaceutical
customers. Some other countries where Bio-Cide operates or seeks
product approval have standards even stricter than the U.S.
government's, he said.
Research and development is a
major Bio-Cide function. The company develops and tests products in
its own laboratories and in labs a several universities. Its
products are sold to 14 countries through distributors and joint
ventures.
"Last year was the 25th
anniversary of Bio-Cide Japan," Danner said. "We invested 35
percent of the capital to build that company, but there are not
enough Japanese government approvals for Bio-Cide to be a major
company yet."
Government standards for germ
control agents differ from country to country, Danner said. "For
instance, the Japanese government doesn't accept U.S. requirements
in food processing and water treatment. No new disinfectants have
been introduced in Japan for 30 or 40 years."
Some Bio-Cide products are
distributed in England, Spain, the Philippines, Australia, New
Zealand, Taiwan and Brazil. Although Bio-Cide still has not
received approval of the European Union, a Bio-Cide partner in
Turkey "will sell some of the company's products in Europe and the
Middle East," Danner said. "Our products are effective against bird
flu."
He said Bio-Cide product test,
under government approved lab conditions, are accepted if they meet
the requirements of regulatory bodies in other countries. "But
there's a political component. We've been waiting on approval for a
couple of our products for years in Europe."
Bio-Cide markets its products
to other manufacturers and pharmaceutical companies that use them
as components in their own products. The company's customers
combine Bio-Cide elements with other ingredients, package the
products and market them under their own brand names.
For example, a Bio-Cide product
is one component of "refresh Tears," a trademarked over-the-counter
wetting agent for contact lenses. Bio-Cide ingredients are in seven
other ophthalmic products, Danner said.
Danner has operated Bio-Cide
International in Norman since 1976. After receiving an engineering
degree from Clemson University, he served as an Air Force officer
on the Atlas missile program, America's first journey into space.
He joined RCA Electronics, where for 10 years he worked on a secret
program to build computers for the Saturn and Apollo missile
programs.
Later, Danner was president and
CEO of an electronics company in Irvine, Calif. In the early '70s,
he bought the rights to develop oxy-chlorine disinfection products.
Among major clients are Boeing, Douglas Aircraft, large food
processing companies and pharmaceutical companies.
Bio-Cide International is a
private corporation with 28 employees in Norman, consultants
throughout the country and worldwide distribution network. Danner
said more employees will likely be needed at the new Norman
facility.
Research, development and
testing are primary reasons for Bio-Cide's new Norman headquarters,
Danner said.
"We're a company that produces
a proprietary specialty chemical," he said. "We're a research
company. Anytime you claim your product kills germs and viruses,
you have to be approved by regulators. You have to develop testing
capabilities to prove it.
"This building represents a new
future for us. It will get us to a new
level."



